Novelties in Diagnostics and Therapeutics in Hepatology: 2nd Edition

A special issue of Gastroenterology Insights (ISSN 2036-7422). This special issue belongs to the section "Liver".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 588

Special Issue Editors


E-Mail Website
Guest Editor
Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, Italy
Interests: liver stiffness; portal hypertension; hepatocellular carcinoma
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Radiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40133 Bologna, Italy
Interests: magnetic resonance imaging; chemoembolization; radiomics; angiography
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Liver diseases are a globally recognized cause of morbidity and mortality. The burden of these diseases has rapidly changed over the last decade due to the introduction in clinical practice of new antiviral agents for hepatitis C virus. Therefore, hepatologists are now tackling the burden of other pathological entities, such as metabolic-associated and hematological-associated liver diseases. A multidimensional diagnostic work-up is needed to ensure the optimal management of these patients. Furthermore, novel techniques and drugs are under investigation for the treatment of advanced stages of liver disease that are complicated by portal hypertension and hepatocellular carcinoma. Within this Special Issue, we will summarize the most updated and cutting-edge research in these fields. The first edition of the special issue can be found in https://www.mdpi.com/journal/gastroent/special_issues/novelties_hepatology.

Dr. Giovanni Marasco
Dr. Matteo Renzulli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Gastroenterology Insights is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • portal hypertension
  • hepatocellular carcinoma
  • imaging
  • liver diseases

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 1063 KiB  
Article
Assessment of Cognitive Function in Romanian Patients with Chronic Alcohol Consumption
by Shandiz Morega, Claudiu-Marinel Ionele, Mihaela-Andreea Podeanu, Dan-Nicolae Florescu and Ion Rogoveanu
Gastroenterol. Insights 2024, 15(2), 433-446; https://doi.org/10.3390/gastroent15020031 - 17 May 2024
Viewed by 427
Abstract
Alcoholism presents a significant health concern with notable socioeconomic implications. Alcohol withdrawal syndrome (AWS) can manifest when individuals cease or drastically reduce their alcohol consumption after prolonged use. Non-alcoholic fatty liver disease (NAFLD) is characterized by substantial lipid accumulation in the liver cells [...] Read more.
Alcoholism presents a significant health concern with notable socioeconomic implications. Alcohol withdrawal syndrome (AWS) can manifest when individuals cease or drastically reduce their alcohol consumption after prolonged use. Non-alcoholic fatty liver disease (NAFLD) is characterized by substantial lipid accumulation in the liver cells of individuals with no history of alcohol consumption. There is evidence suggesting an association between cognitive impairment and both conditions. This study aimed to evaluate cognitive impairment in patients with NAFLD and AWS using the Mini-Mental State Examination (MMSE). This study involved 120 patients admitted to two hospitals in Craiova, Romania. Results indicated that patients with NAFLD did not exhibit cognitive impairment as measured by MMSE (Mean = 29.27, SD = 0.785). Conversely, patients with AWS showed more pronounced cognitive dysfunction, with a mean MMSE score at admission of 16.60 ± 4.097 and 24.60 ± 2.832 after 2 weeks under treatment with Vitamins B1 and B6 and Cerebrolysin. Additionally, our findings suggested that cognitive dysfunction among alcohol consumers was correlated with the severity of clinical symptoms, as demonstrated by the severity of tremors in our study. The two-week period under treatment and alcohol withdrawal was insufficient for cognitive function to return to normal levels. Observational studies on longer periods of time are advised. Full article
(This article belongs to the Special Issue Novelties in Diagnostics and Therapeutics in Hepatology: 2nd Edition)
Show Figures

Figure 1

Back to TopTop